For instance, exosomal delivery of oncomiRNA-155 from CSCs and resistant breast cancer cells to sensitive breast cancer cells mediates the loss of C/EBP-β, which in turn, causes loss of TGF-β and leads to EMT and chemoresistance in recipient cells [54]. Here, CEBPB is linked to breast carcinoma.